Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor

The Journal of Clinical Investigation
Hiroaki ShimokawaA Takeshita

Abstract

Studies in vitro have suggested that inflammatory cytokines may play an important role in the pathogenesis of atherosclerosis. However, little is known about their effects in vivo. Thus, the present study was designed to determine in vivo what histological and functional changes may be induced by chronic treatment with IL-1 beta, one of the major inflammatory cytokines, and also to clarify what mechanisms are involved in those changes. Under aseptic conditions, proximal segments of the left porcine coronary arteries were gently wrapped with cotton mesh absorbing Sepharose beads either with or without recombinant human IL-1 beta. From 1 to 4 wk after the operation, coronary vasospastic responses to intracoronary serotonin or histamine were noted at the IL-1 beta-treated site but not at the control site. Histologically, intimal thickening was greater at the IL-1 beta-treated site than at the control site. Those functional and histological changes induced by the chronic treatment with IL-1 beta were significantly inhibited by the simultaneous treatment with a neutralizing antibody to either IL-1 beta or PDGF. These results indicate that chronic treatment with Il-1 beta induces coronary intimal lesions and vasospastic responses in ...Continue Reading

References

Jan 1, 1992·Microbiology and Immunology·M KitaJ Imanishi
Oct 31, 1985·The New England Journal of Medicine·M B FormanR Virmani
Mar 1, 1985·British Journal of Anaesthesia·W S Nimmo, J G Todd
Aug 1, 1983·Journal of the American College of Cardiology·D D WatersP Théroux
Jul 1, 1980·Circulation Research·S WallensteinJ L Fleiss
Feb 1, 1993·Japanese Circulation Journal·H TashiroA Takeshita

❮ Previous
Next ❯

Citations

May 1, 2001·Biochemical and Biophysical Research Communications·P HoustonM Braddock
Sep 20, 1997·The American Journal of Cardiology·F CreaA Maseri
Mar 12, 1998·Molecular Medicine Today·T L Tuan, L S Nichter
Jan 27, 2010·Immunology and Cell Biology·Philipp FischerRobert A J Oostendorp
Sep 28, 2005·Nature Clinical Practice. Cardiovascular Medicine·Gianluca IacobellisArya M Sharma
Oct 17, 2012·Current Opinion in Lipidology·Arman Qamar, Daniel J Rader
Feb 10, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Attilio MaseriHiroaki Shimokawa
Dec 20, 1999·Japanese Circulation Journal·Y FurukawaS Sasayama
Sep 26, 2002·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Yoji KawanoKozo Kaibuchi
Feb 22, 2012·The Tohoku Journal of Experimental Medicine·Aytun ÇangaÖmer Satiroğlu
Jan 6, 2005·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Yoshitaka Hirooka, Hiroaki Shimokawa
Apr 17, 2012·Internal Medicine·Mustafa ÇetinMehmet Bostan
Nov 12, 2003·Journal of Neurosurgery·Cormac O MaherFredric B Meyer
Dec 14, 2006·Neurological Research·Zhen-Du Zhang, R Loch Macdonald
Dec 11, 2013·Translational Stroke Research·Eric S Hald, Patrick W Alford
Aug 25, 1999·Microvascular Research·T NakazawaH Shigematsu
Nov 3, 2012·Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición·Marcos M Lima-MartínezGianluca Iacobellis
Aug 11, 2000·Kidney International. Supplement·G Lonnemann
Nov 19, 2010·Forensic Science International : Synergy·Katsuyuki NakajimaMasaki Q Fujita
Jun 2, 2015·Circulation Journal : Official Journal of the Japanese Circulation Society·Kensuke NishimiyaHiroaki Shimokawa
Apr 7, 2015·Circulation Journal : Official Journal of the Japanese Circulation Society·Kensuke NishimiyaHiroaki Shimokawa
Jan 29, 2005·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Masanori NakayamaKozo Kaibuchi
Sep 18, 2007·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Kevin R ThomasJoseph P Pestaner
Feb 3, 2005·Free Radical Biology & Medicine·Benjamin J GuikemaDavid Jourd'heuil
May 21, 2004·Revista española de cardiología·Dominick J AngiolilloFilippo Crea
Sep 27, 2005·Atherosclerosis·Nithima ChaowalitFrancisco Lopez-Jimenez
Jul 1, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Kensuke NishimiyaHiroaki Shimokawa
Mar 12, 2015·Journal of the American College of Nutrition·Tomasz Mazurek, Grzegorz Opolski
Apr 29, 2015·Atherosclerosis·Razi KhanPhilippe L L'Allier
Aug 7, 2004·Journal of Vascular Surgery·Zhihua JiangC Keith Ozaki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.